53
Participants
Start Date
June 30, 2007
Primary Completion Date
February 28, 2011
Study Completion Date
April 30, 2011
REOLYSIN®
REOLYSIN® is given intravenously at a dose of 3x10E10 TCID50 over 60 minutes on Days 1-5 of a 28 day cycle.
Montefiore Medical Center/Albert Einstein College of Medicine, The Bronx
University of Michigan Medical School, Ann Arbor
Mayo Clinic, Rochester
Institute of Drug Development, Cancer Therapy Research Center, San Antonio
Lead Sponsor
Oncolytics Biotech
INDUSTRY